IP receptor agonist (Bayer)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameIP receptor agonist (Bayer)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProstanoid IP receptor agonists

TargetsProstanoid IP receptor

Therapy Area/IndicationsHypertension, Pulmonary

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBayer AG

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBayer AG

Active IndicationsN/A

Inactive IndicationsHypertension, Pulmonary

ATC CodeN/A